Key indicators: single-crystal X-ray study; T = 298 K; mean () = 0.000 Å; disorder in main residue; R factor = 0.050; wR factor = 0.144; data-to-parameter ratio = 5.1.
with the phenyl ring, while in the minor component of disorder this angle is 27.5 (5) . The crystal structure is stabilized bystacking interactions between symmetry-related triazole and pyrimidine rings, with centroid-centroid distances of 3.594 (10) Å .
Related literature
For the biological activity of 8-azaguanine derivatives see: Roblin et al. (1945) ; Ding et al. (2004) ; Mitchell et al. (1950) ; Levine et al. (1963) ; Montgomery et al. (1962) ); Yamamoto et al. (1967) ; Bariana (1971) ; Holland et al. (1975) . For related structures, see : Ferguson et al. (1998) For examples of whole-molecule disorder, see: Kirsop et al. (2006) ; Cox & Wardell (2003) . For the preparation, see .
Experimental
Crystal data (Spek, 2009) ; software used to prepare material for publication: SHELXTL97 (Sheldrick, 2008 
Comment
The derivatives of heterocycles containing the 8-azaguanine system, which are well known bioisosteres of guanine, are of great importance because of their remarkable biological properties. Some of these activities include antimicrobial or antifungal activities (Roblin et al., 1945; Ding et al., 2004) , encephaloma cell inhibitor activity (Mitchell et al., 1950; Levine et al., 1963) , antileukemie activity (Montgomery et al., 1962) , hypersusceptibility inhibitor activity and acesodyne activity (Yamamoto et al., 1967; Bariana, 1971; Holland et al., 1975) .
In recent years, we have been engaged in the preparation of the derivatives of 8-azaguanine via aza-Wittig reaction of beta-ethoxycarbonyl iminophosphorane with aromatic isocyanate (Zhao, Xie et al., 2005) . As a continuation of our research for new biologically active heterocycles, the title compound, (I), was obtained from beta-ethoxycarbonyl iminophosphorane and alphalic isocyanate, and the crystal structure is reported herein.
The molecules of (I), which lie in general positions, exhibit 'whole molecule disorder' with the site-occupancy factors of 0.57 (2) and 0.43 (2), (Fig.1) . The bond lengths and angles within the triazolopyrimidinone moiety are in good agreement with those observed for closely related structures. As reported for related compounds (Ferguson et al., 1998; Maldonado et al., 2006; Zeng, Liu et al., 2009; Zhao, Hu et al., 2005; Zhao, Wang & Ding, 2005; Wang et al., 2006 Wang et al., , 2008 Xiao et al., 2007; Chen & Shi, 2006) , all ring atoms in the pyrimidine ring system are essentially coplanar (maximum deviation -0.033 (17) Å for atom N4), indicating that the moiety is a conjugate system.
There are no inter-or intra-molecular hydrogen bonding interactions. The molecular conformation and crystal packing are stabilized by π-π stacking interactions occurring between symmetry realted triazole and pyrimidine rings, with centroidto-centroid distances of 3.594 (10) Å.
Experimental
To a solution of carbodiimide in CH 2 Cl 2 /CH 3 CN (1:4 v/v, 15 ml) prepared according to the literature method , was added p-cresol (3 mmol) and excess K 2 CO 3 . After the reaction mixture was stirred for 12 h. The solvent was removed under reduced pressure and the residue was recrystallized from EtOH to give the title compound (I) In the absense of significant anomalous dispersion effects Friedel pairs were merged. An examination of the data using PLATON (Spek, 2009 ) indicated that the crystal was not twinned. H atoms were placed at calculated positions and treated as riding atoms, with C-H = 0.93-0.98 Å, and U iso (H) = 1.2U eq (C) for CH or 1.5U eq (C) for CH 3 .
Figures Fig. 1 . The molecular structure of (I), showing the atom-labelling scheme. Dashed lines indicate the minor component of disorder. H atoms have been omitted and displacement parameters are drawn at the 50% probability level. 
